Biotest AG

BIESFOTCHealthcare

$32.00

+$0.00(+0.00%)

Market Cap$1.6B

P/E Ratio—

52W High$32

52W Low$30.48

Avg Volume75

Open$32.00

Beta0.00

Net Income Financials Revenue

Biotest AG (BIESF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

BIESF · net income · updated Jun 8, 2026

Core profitability metrics

BIESF · net income · margin · TTM · CAGR

Net income was $26.4M for FY2024 (fiscal year ending 2024-12-31), down 79.2% year-over-year. Net profit margin was 3.6%. Based on available data, Biotest AG has been profitable since at least 2010.

FY2024 Net Income$26.4M▼ -79.2% YoY

Trailing 12M (TTM)−$24.5Mtrailing 4 quarters sum

Net Profit Margin3.6%$26.4M ÷ $726.2M

YoY Change-79.2%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2010

▸ FMP /income-statement · Annual · BIESF net income history · BIESF profit margin

Annual net income data

BIESF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2024$26.4M▼ 79.2%3.6%$726.2M

FY2023$127.0M▲ +500.6%18.6%$684.6M

FY2022Loss−$31.7M▲ +50.0%-6.1%$516.1M

FY2021Loss−$63.4M▼ 101.9%-12.3%$515.6M

FY2020Loss−$31.4M▼ 568.1%-6.5%$484.2M

Net income vs peers (Healthcare)

BIESF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Biotest AGYOU

BIESF

$26.4M-79.2%3.6%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Biotest AG (BIESF) reported net income of $26.4M for FY2024 (fiscal year ending 2024-12-31), down 79.2% year-over-year. The net profit margin was 3.6% — meaning the company kept $0.04 of every dollar of revenue as profit.

Based on available data, Biotest AG has been profitable since at least 2010. Net income reached a peak of $181.3M in FY2018. Data available for 15 fiscal years.

Biotest AG's net profit margin was 3.6% for FY2024, based on the latest annual results.

Investors sometimes search for "Biotest AG net worth" — the company's market capitalization is a separate figure from BIESF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

BIESF net income · 5 questions

Biotest AG is profitable. The company reported net income of $26.4M for FY2024, a net profit margin of 3.6%. Net income was down 79.2% year-over-year. Based on available data, Biotest AG has been profitable since at least 2010.

is BIESF profitabledoes BIESF make a profitBIESF profitabilityBIESF profitable company

▸ Source: FMP /income-statement · GAAP · Biotest AG · Biotest AG SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026